Clinical Trials Browser

INDUSTRY × Interventional × temsirolimus × Clear all

NCT00600496 2025-11-13

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

Phase 1 Active not recruiting

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Phase NA Terminated

225 enrolled 7 charts

Other solid neoplasm

Solid Tumors

NCT01180049 2019-05-20

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Phase 4 Completed

101 enrolled 15 charts

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT01111825 2018-09-26

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

Phase 1/2 Completed

99 enrolled 14 charts

Breast Neoplasms

NCT00838539 2018-09-18

Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors

Phase 1 Completed

63 enrolled 26 charts

Neoplasms

NCT01378377 2018-07-30

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

Phase 1 Terminated

33 enrolled 21 charts

Neoplasms

NCT01827267 2018-07-03

Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

Phase 2 Completed

62 enrolled 12 charts

Lung Neoplasms

NCT01646021 2018-01-19

Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy

Phase 3 Completed

280 enrolled 26 charts

Lymphoma, Mantle-Cell

NCT00631371 2016-04-27

INTORACT

Phase 3 Completed

791 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT00117598 2015-03-30

OPTIMAL

Phase 3 Completed

169 enrolled 15 charts

Lymphoma

NCT00474786 2013-11-21

INTORSECT

Phase 3 Completed

512 enrolled 16 charts

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00106353 2013-02-08

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Phase 1/2 Completed

71 enrolled 42 charts

Adenocarcinoma, Neoplasms

NCT00065468 2012-10-25

ARCC

Phase 3 Completed

626 enrolled 18 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00083993 2011-11-08

Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

Phase 3 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT00563147 2011-10-04

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma

Phase 1 Completed

Carcinoma, Renal Cell

NCT00062751 2011-04-15

Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

Phase 2 Completed

108 enrolled 4 charts

Breast Neoplasms, Neoplasms

NCT00235794 2007-12-27

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Phase NA Completed

Prostatic Neoplasms